AMOXICILLIN, 250mg, disp. and break. tab.
                    STD
                    DORAAMOX2TDB
                
                Valid Article
                            Account code:
                            60000
                        
                        
                            HS Code:
                            300410
                        
                        
                            Last Updated on:
                            30/10/2025, 22:55:17
                        
                    
                Former
                    Code(s):
                     DORAAMOX2TD DORAAMOX2TB
                
            
            
                            
                            
                Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
            
            
                            
                            
                Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
            
            
                                    J01CA04
                            
                Anatomical Therapeutic Chemical Classification according to WHOCC
            
                            
                            
                Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
            
                    AMOXICILLIN
Therapeutic Action
Penicillin antibacterial
Indications
Otitis media, streptococcal tonsillitis, sinusitis, bronchitis, pneumonia
Infection due to Helicobacter pylori (in combination with omeprazole and clarithromycin), leptospirosis, uncomplicated cutaneous anthrax
Completion treatment following treatment with IV penicillins or cephalosporins
Instructions for use
The 250 mg dispersible and breakable tablet is intended for paediatric use and replaces the 250 mg capsule.
The oral suspension form is reserved for neonates up to 2 months of age. To be reconstituted with filtered water.
Storage
- Below 25°C ‐ Protect from sunlight ‐ Protect from humidity
- Oral suspension (powder or reconstituted): follow manufacturer's instructions.
 
                        